
Deliverability and reliability.
Excellent strength, visibility, and deliverability to the renal arteries.
Outstanding design
- Rapid exchange delivery system for single-operator use
- 6F guide compatibility for all stent diameters (4 mm - 7 mm) and lengths (12 mm, 15 mm, 18 mm)
- Cobalt chromium multi-link technology that provides strength and excellent visibility
- Remarkably thin struts with outstanding radial strength
Outstanding performance1
- 74.3% of patients had a reduction in systolic blood pressure at 3 years
- 10.5% restenosis at 9 months
Low Restenosis1
Primary Endpoint

Mean SBP Reduced at 1 Month and Remained Low at 3 Years1

Excellent Freedom from TLR1

Reduced Systolic Blood Pressure
74.3% of patients had a reduction in systolic blood pressure at 3 years1
Stent Compliance Label (CE)

Data on file at Abbott.
References
- Chrysant, George S., et al. Proper Patient Selection Yields Significant and Sustained Reduction in Systolic Blood Pressure Following Renal Artery Stenting in Patients With Uncontrolled Hypertension: Long-Term Results From the HERCULES Trial. The Journal of Clinical Hypertension, 2014 July.
MAT-2115853 v2.0